Mostrando 5 resultados de: 5
Filtros aplicados
Subtipo de publicación
Article(5)
Publisher
Scientific Reports(2)
BMC Infectious Diseases(1)
Nature Communications(1)
The Lancet Infectious Diseases(1)
Área temáticas
Medicina forense; incidencia de enfermedades(4)
Medicina y salud(3)
Enfermedades(2)
Fisiología humana(2)
Biología(1)
Origen
scopus(5)
COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study
ArticleAbstract: The Delta (B.1.617.2) variant was the predominant UK circulating SARS-CoV-2 strain between May and DPalabras claves:Autores:Aanensen D.M., Abudahab K., Adams A., Adams H., Afifi S., Aggarwal D., Ahmad S.S.Y., Aigrain L., Alcolea-Medina A., Alikhan N.F., Allara E., Amato R., Angyal A., Annett T., Antonelli M., Aplin S., Ariani C.V., Asad H., Ash A., Ashfield P., Ashford F., Atkinson L., Attwood S.W., Auckland C., Aydin A., Baker D.J., Baker P., Balcazar C.E., Ball J., Barrett J.C., Barrow M., Barton E., Bashton M., Bassett A.R., Batra R., Baxter C., Bayzid N., Beaver C., Beckett A.H., Beckwith S.M., Bedford L., Beer R., Beggs A., Bellis K.L., Bernardo M. Gutierrez, Berry L., Bertolusso B., Best A., Betteridge E., Bibby D., Bicknell K., Binns D., Birchley A., Bird P.W., Bishop C., Blacow R., Blakey V., Blane B., Bolt F., Bonfield J., Bonner S., Bonsall D., Boswell T., Bosworth A., Bourgeois Y., Boyd O., Bradley D.T., Breen C., Bresner C., Breuer J., Bridgett S., Bronner I.F., Brooks E., Broos A., Brown J.R., Bucca G., Buchan S.L., Buck D., Bull M., Burns P.J., Burton-Fanning S., Byaruhanga T., Byott M., Campbell S., Canas L.S., Capdevila J., Carabelli A.M., Cargill J.S., Carlile M., Carvalho S.F., Chen L., Deng J., Fox B., Graham M.S., Kerfoot E., Kläser K., May A., Molteni E., Murray B., Österdahl M.F., Wolf J.Fuentes:scopusGenomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission
ArticleAbstract: Mitigation of SARS-CoV-2 transmission from international travel is a priority. We evaluated the effePalabras claves:Autores:Aanensen D.M., Abudahab K., Adams H., Afifi S., Aggarwal D., Ash A., Batra R., Beckett A.H., Beer R., Bernardo M. Gutierrez, Berry L., Bird P.W., Blakey V., Bonsall D., Boswell T., Bresner C., Campbell S., Carlile M., Charalampous T., Chen C., Clark G., Cogger B.J., Coll F., Connor T.R., Cortes N., Curran T., Debebe J., Edgeworth J., Ellaby N., Fairley D.J., Fallon K., Fleming V.M., Fraser C., Fuller W., Gallagher E., Golubchik T., Groves N., Guest M., Gulliver H., Harrison A., Hassan-Ibrahim M.O., Helmer T., Holmes C., Holmes N., Howson-Wells H.C., Hughes G.J., John M., Jones C., Joseph A., Khakh M., Kidd S., Kitchen C., Koshy C., Le Viet T., Lister M.M., Logan S., Loose M.W., Lynch J., Maksimovic J., Malone C.S., Marchbank A., McCluggage K., McKenna J.P., Menegazzo M., Merrick I., Moore C., Moore N., Morgan S., Mori M., Munn R., Myers R., Nebbia G., Page A.J., Patel A., Platt S., Price A., Raviprakash V., Reynolds N., Robson S.C., Sang F., Savva G.M., Schaefer U., Sheriff N., Smith W., Snell L.B., Southgate J., Spellman K., Tang J., Taylor B.E.W., Tumelty N.M., Turner C., Underwood A.P., Volz E.M., Wantoch M., Warne B., Williams L.A., Willingham I., Wise E.L., Workman T., Wright V., Yeats C.A.Fuentes:scopusGenomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planning
ArticleAbstract: Whole genome sequencing of SARS-CoV-2 has occurred at an unprecedented scale, and can be exploited fPalabras claves:Autores:Aanensen D.M., Aggarwal D., Amato R., Ariani C.V., Barrett J.C., Bashton M., Beckett A.H., Beckwith S.M., Bernardo M. Gutierrez, Bonsall D., Bucca G., Bull M., Burns P.J., Byott M., Carabelli A.M., Carmichael S., Christofidis N., Connor T.R., Corden S., Cortes N., Cottrell S., Curran M.D., de Silva T.I., Eastick K., Enright J., Fairley D.J., Frampton D., Glaysher S., Goldstein E.J., Golubchik T., Goncalves S., Goodfellow I.G., Griffiths E., Gunson R.N., Hamilton W.L., Harrison E.M., Hassan-Ibrahim M.O., Holden M.T.G., Houlihan C., Hughes J., Jackson D.K., Jackson L.M., Johnston I., Kwiatkowski D.P., Langford C.F., Levett L.J., Liggett S., Lillie P.J., Livett R., Loman N.J., Loose M.W., Loveson K.F., Ludden C., Lythgoe K., Mahungu T.W., Moore C., Moore N., Moses S., Murray A., Nastouli E., Nebbia G., Nicholls S.M., Nickbakhsh S., Nomikou K., Nunez R.T.M., Orton R.J., Osman H., O’Grady J., Pacchiarini N., Palmalux N., Parker M.D., Parmar S., Pope C.F., Prieto J.A., Rambaut A., Randell P., Robson S.C., Rogan F., Saeed K., Shaaban S., Shepherd J.G., Sheridan L.A., Sillitoe J., Simpson D.A., Singleton D., Smith C.P., Smith D.L., Smollett K., Snell L.B., Sreenu V.B., Templeton K.E., Thomas C., Thomson E.C., Tomb R.M., Tong L., Torok M.E., Underwood A.P., Wang D., Watkins J., Williams C., Witney A.A.Fuentes:scopusHospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
ArticleAbstract: Background: The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March, 2021. IPalabras claves:Autores:Aanensen D.M., Abudahab K., Adams H., Afifi S., Aliabadi S., Ash A., Batra R., Beckett A.H., Beer R., Bernardo M. Gutierrez, Berry L., Betancor G., Bird P.W., Blakey V., Bonsall D., Boswell T., Bresner C., Campbell S., Carlile M., Charalampous T., Charlett A., Clark G., Cogger B.J., Coll F., Connor T.R., Cortes N., Curran T., Dabrera G., De Angelis D., Debebe J., Edgeworth J., Fairley D.J., Fallon K., Fleming V.M., Fraser C., Fuller W., Gallagher E., Golubchik T., Guest M., Gulliver H., Harris R.J., Hassan-Ibrahim M.O., Helmer T., Holmes C., Holmes N., Hope R., Howson-Wells H.C., John M., Jones C., Joseph A., Khakh M., Kidd S., Kitchen C., Koshy C., Lister M.M., Loose M.W., Lopez-Bernal J., Lynch J., Maksimovic J., Malone C.S., Marchbank A., McCluggage K., McKenna J.P., Menegazzo M., Merrick I., Moore C., Moore N., Morgan S., Mori M., Munn R., Nebbia G., Nyberg T., Patel A., Presanis A.M., Price A., Raviprakash V., Reynolds N., Robson S.C., Sang F., Seaman S.R., Sheriff N., Signell A.W., Sinnathamby M.A., Smith W., Snell L.B., Southgate J., Spellman K., Tang J., Taylor B.E.W., Thelwall S., Twohig K.A., Underwood A.P., Wantoch M., Warne B., Williams L.A., Willingham I., Wise E.L., Workman T., Wright V., Yeats C.A., Zaidi A.Fuentes:scopusSARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2
ArticleAbstract: Background: Since the emergence of SARS-CoV-2, evolutionary pressure has driven large increases in tPalabras claves:covid-19, Delta variant, GENETIC DIVERSITY, mutation, SARS-COV-2, Transmission advantageAutores:Aanensen D.M., Aggarwal D., Amato R., Ariani C.V., Atchison C., Barrett J.C., Bashton M., Beckett A.H., Beckwith S.M., Bernardo M. Gutierrez, Bodinier B., Bonsall D., Bucca G., Bull M., Burns P.J., Byott M., Carabelli A.M., Chand M., Connor T.R., Corden S., Cortes N., Cottrell S., Curran M.D., Darby A.C., De Angelis D., de Oliveira Martins L., de Silva T.I., Eales O., Eastick K., Fairley D.J., Frampton D., Glaysher S., Golubchik T., Goncalves S., Goodfellow I.G., Gunson R.N., Gupta R.K., Hamilton W.L., Harrison E.M., Hassan-Ibrahim M.O., Haw D., Holden M.T.G., Houlihan C., Jackson D.K., Jackson L.M., Johnston I., Jonnerby J., Kwiatkowski D.P., Langford C.F., Levett L.J., Liggett S., Lillie P.J., Livett R., Loman N.J., Loose M.W., Loveson K.F., Ludden C., Lythgoe K., Mahungu T.W., Moore C., Moore N., Moses S., Murray A., Nastouli E., Nebbia G., Nicholls S.M., Nunez R.T.M., Osman H., O’Grady J., Pacchiarini N., Page A.J., Parker M.D., Parmar S., Paterson S., Pope C.F., Prieto J.A., Pybus O.G., Rambaut A., Randell P., Robson S.C., Rogan F., Saeed K., Shepherd J.G., Sheridan L.A., Sillitoe J., Simpson D.A., Singleton D., Smith C.P., Smith D.L., Snell L.B., Templeton K.E., Thomas C., Thomson E.C., Torok M.E., Underwood A.P., Volz E.M., Wang D., Wang H., Watkins J., Williams C., Witney A.A.Fuentes:scopus